Movement Disorders in Subacute Sclerosing Panencephalitis Patients
Objective: We aimed to study the frequency of movement Disorders other than myoclonus seen in patients with subacute sclerosing panencephalitis (SSPE). Background: SSPE is a…Analysis of handgrip strength, upper limb traction and ground reaction force on bus step climb in healthy elderly subjects and individuals with Parkinson’s disease
Objective: To analyze and compare the strength hand, upper limbs traction strength and the ground reaction force (FRS) during step up in a bus, in…An International Pre-Implementation Survey To Assess The Acceptability Of Telemedicine As An Alternative To In-Person Clinic Consultations For PD
Objective: To assess the acceptability of virtual consultations as an option for out-patient clinic consultations for PD Background: The practice of telemedicine increased dramatically on…Trunk postural control in seated position on a prototype of unstable chair and the interference of cognitive and motor tasks in individuals with Parkinson disease
Objective: To analyze trunk balance control of individuals with Parkinson disease (PD) in seated position and compare the control position with motor and cognitive tasks.…Central pain in Parkinson’s disease
Objective: The objective of our study is to assess the prevalence of central pain in patients with parkinson’s diseaseThe objective of our study is to…Cinpanemab in Parkinson’s Disease: Imaging and Fluid Biomarker Results from the Phase 2 SPARK Study
Objective: To evaluate the effects of cinpanemab on biomarkers in participants with Parkinson’s disease (PD). Background: SPARK (NCT03318523) was designed to evaluate the safety, pharmacokinetics,…Amantadine DR/ER-Related Reduction in OFF and Dyskinesia Improved Patient-Rated Interference with Activities and Social Interactions
Objective: Evaluate dyskinesia and OFF interference with activities and experiences for persons with Parkinson disease (PWPD), and mitigation with treatment Background: OFF and Dyskinesia remain…Effect of Venglustat by GBA Mutation Severity in Patients With Parkinson’s Disease
Objective: Report outcomes from Part 2 of the phase 2 MOVES-PD trial (NCT02906020) in patients with PD stratified by glucocerebrosidase (GBA) gene mutation severity. Background:…Amantadine DR/ER Efficacy as Early Add-On for Motor Complications in Parkinson’s Disease
Objective: Utilize clinical trial data to analyze amantadine delayed release/extended release (AMT DR/ER) capsules as an early add-on for OFF and dyskinesia in people with…Validation of the Neuroprotective Potential of SLP-2 against alpha-synuclein neuropathology in a Mouse Model of Parkinson’s Disease
Objective: We aim to validate the neuroprotective potential of SLP-2 against α-syn neuropathology and neurodegeneration of dopaminergic neurons in a mouse model of Parkinson’s disease.…
- « Previous Page
- 1
- …
- 108
- 109
- 110
- 111
- 112
- …
- 132
- Next Page »